GLP-1 receptor agonist compounds having stabilized regions

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9217022
APP PUB NO 20130184203A1
SERIAL NO

13812445

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The disclosure provides GLP-1 receptor agonist compounds having stabilized regions corresponding to alpha-helical regions of the natural peptide compounds. The disclosure also provides benzamide-containing exendin-4 analogs and alkene-constrained exendin-4 analogs, both of which have stabilized regions corresponding to alpha-helical regions of exendin-4.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASTRAZENECA PHARMACEUTICALS LP1800 CONCORD PIKE P O BOX 15437 WILMINGTON DE 19850-5437

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Alfaro-Lopez, Josue San Diego, US 7 220
Coats, Eugene Wilmington, US 1 17
Ghosh, Soumitra S Wilmington, US 82 1785
Sharma, Abhinandini San Diego, US 7 100
Soares, Christopher J Wilmington, US 27 1120

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 22, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00